Shah, R. G., Merlin, M. A., Adant, S., Zine-Eddine, F., Beauregard, J., & Shah, G. M. (2021). Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of (177)Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells. Cancers (Basel).
Citación estilo ChicagoShah, Rashmi G., Marine A. Merlin, Samuel Adant, Fayçal Zine-Eddine, Jean-Mathieu Beauregard, y Girish M. Shah. "Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of (177)Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells." Cancers (Basel) 2021.
Cita MLAShah, Rashmi G., et al. "Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of (177)Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells." Cancers (Basel) 2021.